certain decided advantages. It is stable at room temperature, does not require special storage, is inexpensive, less invasive to use, has no bronchoconstrictor action and can be administered through several routes. There has been concern about uterine hyper stimulation with the use of higher doses of Misoprostol. Recent published studies have, however, established that lower dosages of Misoprostol give similar or better results than PGE 2 , but with similar safety profile. [3] [4] [5] The 25 µg dose is as effective as the 50 µg dose and with reduced risk of hyperstimulation. 6 This study aims to compare the efficacy and safety of low dose (25µg) vaginal Misoprostol with intracervical Dinoprostone for cervical ripening and induction of labour in term pregnancies.
METHODS
This was a retrospective study conducted from Jan 2011 The present study on the "Comparative Evaluation of Low dose-Vaginal Misoprostol and Intracervical Dinoprostone for Cervical Ripening and Induction of Labour in Term Pregnancy" was conducted on 200 term gravidas admitted in the antenatal ward/labour room of Department of Obstetrics and Gynaecology, Shri Guru Tegh Bahadur Hospital/ Bebe Nanke Centre for Mother and Child Care, Government Medical College, Amritsar. After approval from the Hospital Ethics Committee, informed consents were obtained from each participant. Allocation to the two study groups was carried out through computer generated randomisation sequence sealed in an opaque envelope.
All term gravidas >18 years old, with accurately dated single viable cephalic gestation, a Bishop's score of <5 and a reactive non stress test prior to induction were included in the study.
Grand multiparas, women with history of prior uterine surgery, any suspicious vaginal bleeding, multiple pregnancies, suspected cephalopelvic disproportion, non vertex presentation, abnormal placentation and history to cardiac disease, glaucoma, asthma, or drug allergy were excluded from the study.
A detailed history was taken and a comprehensive general physical, systemic and obstetric examination was carried out.
After the assessment of the cervical Bishop's score following a reactive NST, patients were allocated to two groups. Patients in group A were administered 0.5 mg Dinoprostone gel (Cerviprime Gel 0.5mg, Astra Zeneca) intracervically and those in group B were administered 25 µg Misoprostol tablet (Tab Misoprost 25µg, Cipla) per vaginum.
In both groups, the blood pressure, pulse rate, uterine activity and foetal heart rate were monitored and noted every 15 minutes for the first hour and half hourly thereafter. The onset of uterine contractions, duration, frequency and intensity of contractions were noted and patient was monitored for uterine tachysystole, hyper tonus, hyper stimulation or non-reassuring foetal heart rate patterns.
If and when the patient went into active labour, liquor was meconium stained or the FHR was not reassuring, the patient was transferred to the labour room and further prostaglandin doses were withheld. After the administration of the first dose, the patient vitals, fetal heart rate and onset of uterine contractions were monitored. If at 6 hrs, good uterine contractions (2 or more lasting 25-30 seconds each in a 10 minute period) were established and Bishop's Score >5, further doses were withheld and, augmentation, if and when required was carried out with oxytocin infusion and amniotomy. If there were no adequate pains or for Bishop's Score <5, doses were repeated at 6, 12 and 18 hrs. Successful induction was defined as the occurrence of vaginal delivery within 24 hrs. In the event of uterine hyper stimulation, the patient was put in left lateral position, intranasal oxygen inhalation was given and intravenous Dextrose Normal Saline drip was started. Tocolytics were administered for reversal of hyper stimulation. The trial was interrupted and decision for operative intervention taken, if the aforementioned measures failed. Caesarean section was performed for failure to progress and fetal distress.
For the purpose of the trial, foetal distress was defined as persistent or recurring episodes of severe variable or late decelerations, late decelerations, or prolonged foetal bradycardia, or a combination of decreased beat-to-beat variability and a decelarative pattern with or without the presence of meconium stained liquor. Non progress of labour was defined as no change in cervical dilatation during the active phase of labour for two consecutive hours or no progress in the descent of the foetus through the birth canal in the second stage of labour for 1 hour in the presence of adequate uterine contractions.
The primary outcome measures studied were the number of vaginal deliveries occurring within 24 hours and the induction-to-vaginal delivery interval. The secondary outcome measures were the number of prostaglandin doses required, need for oxytocin augmentation, duration of labour, maternal hyper stimulation and foetal outcome as described by need for resuscitation in the labour room, APGAR scores at 1 and 5 minutes and admission to the NICU.
Statistical analysis
Statistical analysis was performed on the SPSS Version 20. Continuous data was reported as mean±SD. Analysis of continuous data was accomplished by means of a two tailed Student-t test. The χ 2 test or Fischer's exact test was used to compare the non parametric data.
RESULTS
The patients in both groups were similar with respect to age, gestational age, parity, pre induction cervical score and indication for induction (Table 1) . No patients were excluded from analysis. No patients were lost to follow up. Table 2) .
The need for augmentation with oxytocin was significantly greater in the Dinoprostone group as compared to the Misoprostol group (p <0.001). The incidence of hyper tonus, tachysystole and hyper stimulation were similar in the two groups (16% v/s 14%) (p= 0.733) ( Table 2 ). The commonly encountered side effects were nausea, vomiting, diarrhoea and pyrexia which were comparable in the two groups (p= 0.105). There were no uterine ruptures in either group. The main indications for Caesarean section in both groups were fetal distress and non progress of labour, and were comparable in both groups (p=0.333).
Majority of neonates (78% in either treatment group) did not have any perinatal complications. The rate of meconium stained liquor was higher in the Misoprostol group as compared to the Dinoprostone group. The rates of other neonatal complications were similar in the two groups (p= 0.244) ( Table 3 ). There were no intra uterine deaths or early neonatal deaths in either group. A Cochrane review has noted a higher rate of uterine stimulation with Misoprostol but no increase in maternal morbidity, foetal adverse outcome or Caesarean birth rates. It has further stated that hyper stimulation is likely a dose dependent phenomenon, and in studies using 25 µg Misoprostol, hyper stimulation rates are similar to those induced with Dinoprostone. 14 There was no uterine rupture in our study. Blanchette et al have reported four uterine ruptures in their study. However, it is of note that patients with previous caesarean sections were included in their study. 9 3 of 4 ruptures occurred in scarred uteri whereas a one posterior rupture occurred in a case of shoulder dystocia. In our study, the risk of meconium stained liquor was greater in the Misoprostol group. However, the overall neonatal outcome was similar with both drugs.
The WHO included 25 µg Misoprostol in its essential drugs list in 2007. 15 In its 2011 recommendations for labour induction, it has proposed the use of 25µg vaginal Misoprostol for induction of labour in an unscarred uterus, thus lending further credibility to Misoprostol's claim as an efficacious and safe labour induction agent. 7
CONCLUSION
Low dose vaginal Misoprostol is a more efficacious agent for labour induction and cervical ripening than intracervical Dinoprostone, but with an identical safety profile. Its use is less cumbersome and more cost effective. It has, therefore, an immense potential for application in labour induction especially in the developing world and resource poor settings.
